GARRETT SMITH: Open Payments
NPI 1669587630 · LINDON, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$882 in 56 payments from 20 companies in 2025. Trend: 2023 $918 · 2024 $895 · 2025 $882
Food & beverage: $882
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $227 |
| Astellas Pharma US Inc | 6 | $104 |
| PFIZER INC. | 5 | $87 |
| Phathom Pharmaceuticals, Inc. | 6 | $74 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| Axsome Therapeutics, Inc. | 2 | $41 |
| Abbott Laboratories | 2 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
| Lilly USA, LLC | 2 | $32 |
| Medtronic, Inc. | 2 | $30 |
Products named: VRAYLAR, Veozah, VOQUEZNA, UBRELVY, AIRSUPRA, PREVNAR 20, FREESTYLE LIBRE 3, Kerendia.
Industry payments across UT — which companies pay providers there.
